France

Paediatric oncologist involved in early drug development:

• Dr. Nathalie GASPAR, Gustave Roussy Villejuif

Medical oncologist involved in early drug development:

• Dr. Maud TOULMONDE, Institut Bergonié Bordeaux
• Dr. Christophe MASSARD, Gustave Roussy Villejuif

Contact

Carole LECINSE

ITCC Project Manager/Accelerate FAIR Group coordination

carole.lecinse@gustaveroussy.fr

What does this theme represent for your country?

Pediatric Oncologist(s) and Medical Oncologist(s):

France have been pioneer in favoring age inclusive research for adolescent and young adults in oncology from early drug development. All the actors of the drug development are involved. Pediatric and medical oncologists have started to work together from early drug development helped by the national cancer institute (INCa) within the frame of the CLIP2 (https://www.e-cancer.fr/Professionnels-de-la-recherche/Recherche-clinique/Structuration-de-la-recherche-clinique/Les-CLIP2). French authorities such as ANSM (Agence nationale de sécurité du médicament et des produits de santé) are willing to push the initiative, along with the ethics committees. The pharma implicated in the LEEM (les entreprises du medicament; https://www.leem.org/) support the initiative. Patient and parent advocates have been very active in promoting and disseminating the idea of including adolescents in adult trials from early drug development. Although all the perceived breaks have not fully disappeared, a positive dynamics has started that we try to push forward for the benefit of adolescents and young adults with cancer.